Yukihiko Kato - Concepedia

Author

Yukihiko Kato

Tokyo Medical University ORCID

Also Known As

H Xu, Y KATO, Y Kato, Y. Kato, Y., Kato, YUKIHIKO KATO, Yukihiko KATO, Yukihiko Kato, Yukihiko Kato,

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Tokyo Medical University Sidney Kimmel Comprehensive Cancer Center Tokyo Metropolitan Tama Medical Center Johns Hopkins University Novartis (United States)

About

Yukihiko Kato is an author at Tokyo Medical University specializing in medicine, immunology, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	661
2	Engineering	1	1	14
3	Health Sciences	1	1	17
4	Public Health	1	1	14
5	Allergy	1	1	17

Yukihiko Kato

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Targeting Tumor Angiogenesis with Histone Deacetylase Inhibitors: the Hydroxamic Acid Derivative LBH589 David Z. Qian, Yukihiko Kato, Shabana Shabbeer, Clinical Cancer Research	2006	272
The Histone Deacetylase Inhibitor NVP-LAQ824 Inhibits Angiogenesis and Has a Greater Antitumor Effect in Combination with the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor PTK787/ZK222584 David Z. Qian, Xiaofei Wang, Sushant K. Kachhap, Cancer Research Tumor BiologyGreater Antitumor EffectInhibit Tumor GrowthAngiogenesisChemoprevention Strategy	2004	229
Sequence Diversity of the Intergenic Spacer Region of the rRNA Gene of <i>Malassezia globosa</i> Colonizing the Skin of Patients with Atopic Dermatitis and Healthy Individuals Takashi Sugita, Minako Kodama, Masuyoshi Saito, Journal of Clinical Microbiology Healthy SubjectsGenetic EpidemiologyImmunologySkin AllergyMolecular Genetics	2003	99
Synergistic <i>In vivo</i> Antitumor Effect of the Histone Deacetylase Inhibitor MS-275 in Combination with Interleukin 2 in a Murine Model of Renal Cell Carcinoma Yukihiko Kato, Kiyoshi Yoshimura, Tahiro Shin, Clinical Cancer Research	2007	84
Integrin α2 Mediates Selective Metastasis to the Liver Kiyoshi Yoshimura, Kristen F. Meckel, Lindsay S. Laird, Cancer Research ImmunologyPathologyCancer BiologyTumor BiologyIntegrin α2	2009	84
Epigenetic Modulation of Retinoic Acid Receptor β2 by the Histone Deacetylase Inhibitor MS-275 in Human Renal Cell Carcinoma Xiaofei Wang, David Z. Qian, Mingqiang Ren, Clinical Cancer Research	2005	75
Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-<i>cis</i>-retinoic acid in human malignant melanoma Yukihiko Kato, Brenda Salumbides, Xiao-Fei Wang, Molecular Cancer Therapeutics	2007	74
Antitumor activity of the histone deacetylase inhibitor MS‐275 in prostate cancer models David Z. Qian, Yongfeng Wei, Xiaofei Wang, The Prostate	2007	69
Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteins Hirofumi Shibuya, Yukihiko Kato, Masuyoshi Saito, Melanoma Research Chemoprevention StrategyApoptosisImmunologyCell DeathTumor Biology	2003	45
Improvement of dermatitis by iontophoretically delivered antisense oligonucleotides for interleukin-10 in NC/Nga mice Takatoshi Sakamoto, E Miyazaki, Yukihiko Aramaki, Gene Therapy InflammationAutoimmune DiseaseAtopic DermatitisImmunologyNc/nga Mice	2004	44

Page 1